NorthWest Biotherapeutics Inc (NWBO)

[safin]

On the contrary, I think the truth will win out and as more successful trial data emerges the company will report it. In about 3 weeks, the rest of the 11 patients in the 20 patient cohort (of which 9 were recently reported on) will reach their 8 week (4th injection) mark. If their results are similar to the initial 9, NWBO will of course report it, with the same caveats about future results being better or worse. And not long after that, the initial 9 will be receiving their 5th treatment. At some point, in the face of continued good results AF's attacks will lose their sting and perhaps (and rightfully) be ignored altogether.